Efficacy and side effects of subcutaneous pasireotide alone or in combination with cabergoline in patients with cushing's disease whithout postoperative remission | Synapse
May 6, 2024
Efficacy and side effects of subcutaneous pasireotide alone or in combination with cabergoline in patients with cushing's disease whithout postoperative remission
Key Points
Key points are not available for this paper at this time.
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)